This page lists the paediatric cardiology hospitals in our directory offering Right Heart Catheterization in Mumbai, India, including Nanavati Super Specialty Hospital, Kokilaben Dhirubhai Ambani Hospital, Tata Memorial Hospital, Apollo Hospitals, Navi Mumbai and others. Each listing links through to the hospital's full profile page.
Ask us about right heart catheterization in Mumbai, India
Share a few details and our care coordination team will get back to you with next steps.
Compare 17 accredited hospitals for Paediatric Cardiology in Mumbai, India
Featured🇮🇳 Nanavati Super Specialty Hospital
Ranks #1 in this list by listed rating (5/5 from 12 reviews).
🇮🇳 Kokilaben Dhirubhai Ambani Hospital
Ranks #2 in this list by listed rating (4.8/5 from 1800 reviews).
🇮🇳 Tata Memorial Hospital
Ranks #3 in this list by listed rating (4.8/5 from 2500 reviews).
🇮🇳 Apollo Hospitals, Navi Mumbai
Ranks #4 in this list by listed rating (4.8/5 from 512 reviews).
🇮🇳 Gleneagles Hospital, Mumbai
Ranks #5 in this list by listed rating (4.8/5 from 615 reviews).
🇮🇳 Lilavati Hospital And Research Centre
Ranks #6 in this list by listed rating (4.8/5 from 724 reviews).
🇮🇳 Jaslok Hospital
Ranks #7 in this list by listed rating (4.6/5 from 129 reviews).
🇮🇳 Gleneagles Global Hospitals (Global Hospitals)
Ranks #8 in this list by listed rating (4.6/5 from 183 reviews).
🇮🇳 Medicover Hospital, Navi Mumbai
Ranks #9 in this list by listed rating (4.6/5 from 143 reviews).
🇮🇳 KIMS Hospitals, Thane
Ranks #10 in this list by listed rating (4.6/5 from 58 reviews).
🇮🇳 Fortis Hospital, Mulund
Ranks #11 in this list by listed rating (4.5/5 from 79 reviews).
🇮🇳 Fortis Hiranandani Hospital, Vashi
Ranks #12 in this list by listed rating (4.5/5 from 83 reviews).
🇮🇳 Wockhardt Hospital
Ranks #13 in this list by listed rating (4.4/5 from 30 reviews).
🇮🇳 Wockhardt Super Speciality Hospital
Ranks #14 in this list by listed rating (4.4/5 from 48 reviews).
🇮🇳 S. L. Raheja Hospital
Ranks #15 in this list by listed rating (4.4/5 from 121 reviews).
🇮🇳 Saifee Hospital
Ranks #16 in this list by listed rating (4.3/5 from 97 reviews).
🇮🇳 Dr. L H Hiranandani Hospital
Ranks #17 in this list by listed rating (4.3/5 from 141 reviews).
How we selected these hospitals
A hospital appears on this page when Paediatric Cardiology is among its listed specialties and it is located in Mumbai, India. Hospitals are not ranked by a proprietary "best" score — the order follows the listed rating (highest first), the same field shown on each hospital's profile.
How to Select the Best Hospital for Right Heart Catheterization in Mumbai, India?
Choosing the right hospital for right heart catheterization is one of the most important decisions in your treatment journey. A few factors are worth weighing before you decide:
International Accreditation
Look for a hospital with international accreditation such as JCI or NABH — see the accreditation badges shown for each hospital below.
Specialization
Check that the hospital's listed specialties actually include paediatric cardiology rather than only general care.
Capacity and Track Record
Bed count and year established (shown below for each hospital) are a reasonable proxy for scale and operating experience.
Transparent Costs
Ask for an itemised, all-inclusive estimate — hospital charges, room category and stay — before you travel. Our cost calculator (linked below) gives a starting estimate.
Understanding Right Heart Catheterization
Right Heart Catheterisation (RHC) is a precision diagnostic and interventional procedure used to directly measure haemodynamic parameters — including pulmonary artery pressure, pulmonary vascular resistance, and cardiac output — that are essential for diagnosing and managing complex congenital and acquired heart conditions in paediatric patients. The procedure carries a diagnostic accuracy exceeding 95% and is considered the gold standard for evaluating pulmonary hypertension, intracardiac shunts, and pre-operative cardiac physiology in children. International families choose India and the UAE through GAF Healthcare for access to world-class paediatric cardiac centres staffed by fellowship-trained interventional cardiologists, equipped with state-of-the-art catheterisation laboratories, at costs significantly below those in Western countries. Hospital Stay: 1–3 days (typically day-procedure or overnight observation; complex cases requiring concurrent intervention may require up to 3 days) • Total Stay in Country (Fit-to-Fly): 1–2 weeks (short-haul flights may be cleared at 5–7 days post-procedure; long-haul international flights generally require physician clearance at 7–14 days, subject to the child's haemodynamic stability and any concurrent interventions performed) • Success Rate: 95–98% (diagnostic yield; procedural complication rates in high-volume paediatric centres are below 1–2%)
Clinical Overview
Right Heart Catheterisation is the definitive invasive haemodynamic investigation of the right-sided cardiac chambers and the pulmonary vasculature. A thin, flexible catheter — most commonly a Swan-Ganz or a custom paediatric end-hole catheter — is advanced under fluoroscopic and/or echocardiographic guidance from a peripheral venous access site (typically the femoral vein, internal jugular vein, or — in neonates — the umbilical vein) through the right atrium, right ventricle, and into the pulmonary artery. At each anatomical station, the cardiologist records direct pressure waveforms, oxygen saturations, and thermodilution or Fick-principle cardiac output measurements, generating a comprehensive haemodynamic profile that no non-invasive modality can replicate with equivalent precision. In the paediatric context, RHC is indispensable for characterising the severity of pulmonary arterial hypertension (PAH) — including Eisenmenger physiology — quantifying the magnitude of left-to-right shunts (Qp:Qs ratio), assessing pulmonary vascular resistance (PVR) indexed to body surface area (PVRi in Wood Units·m²), and determining the reversibility of elevated PVR through acute vasoreactivity testing (AVT) using inhaled nitric oxide (iNO) at 20–40 ppm, intravenous adenosine, or inhaled iloprost. A positive vasoreactivity response — defined by the modified Sitbon criteria as a reduction in mean pulmonary artery pressure (mPAP) of ≥10 mmHg to an absolute value of ≤40 mmHg with maintained or improved cardiac output — has critical therapeutic and prognostic implications, determining eligibility for calcium channel blocker therapy versus advanced PAH-targeted pharmacotherapy. The standard of care at accredited paediatric cardiac centres integrates RHC with simultaneous balloon occlusion (wedge) pressure measurement to derive the transpulmonary gradient (TPG) and pulmonary vascular resistance index (PVRi), angiocardiography with selective contrast injections for morphological delineation, and — when indicated — combined diagnostic and interventional procedures such as balloon atrial septostomy, blade septostomy, transcatheter device closure of atrial or ventricular septal defects (ASD/VSD), or pulmonary artery balloon angioplasty and stenting. Digital flat-panel detector catheterisation laboratories with 3D rotational angiography (3DRA), intracardiac echocardiography (ICE), and pressure-wire-based fractional flow reserve (FFR) capability are now standard at the leading centres accessible through GAF Healthcare.
Who is a Candidate?
• ELIGIBLE PATIENTS: • Children and adolescents with confirmed or suspected pulmonary arterial hypertension (Group 1 PAH), including idiopathic PAH (IPAH), heritable PAH (BMPR2, ALK1, ENG mutations), and PAH associated with congenital heart disease (PAH-CHD) • Patients with complex congenital heart disease (CHD) requiring pre-operative haemodynamic assessment — including tetralogy of Fallot (TOF), transposition of the great arteries (TGA), single ventricle physiology (prior to Glenn or Fontan completion), atrioventricular septal defects (AVSD), and anomalous pulmonary venous connections (TAPVC/PAPVC) • Paediatric patients with unexplained dyspnoea, exercise intolerance, or syncope where non-invasive testing (echocardiography, cardiac MRI) is inconclusive • Patients being evaluated for advanced heart failure therapies, including cardiac transplantation or mechanical circulatory support (MCS), requiring transplant haemodynamic profiling • Post-operative surveillance following CHD repair, Fontan palliation, or pulmonary artery reconstruction, to assess residual haemodynamic lesions • Patients with connective tissue diseases (systemic lupus erythematosus, systemic sclerosis, juvenile idiopathic arthritis) and suspected pulmonary vascular involvement • Children with sickle cell disease, liver disease (portopulmonary hypertension), or HIV with suspected PAH • REQUIRED PRE-PROCEDURAL DIAGNOSTICS: • Transthoracic Echocardiography (TTE) with Doppler — mandatory; estimates PA pressures via tricuspid regurgitation jet velocity, assesses ventricular function, valve morphology, and shunt anatomy • Cardiac MRI (CMR) — for ventricular volumetry, myocardial tissue characterisation, and pulmonary flow quantification (Qp:Qs) where echo is limited • CT Pulmonary Angiography (CTPA) — to exclude chronic thromboembolic disease (CTEPH) and delineate pulmonary vascular anatomy • Six-Minute Walk Test (6MWT) or cardiopulmonary exercise testing (CPET) — functional capacity baseline in cooperative children (≥5 years) • Pulmonary Function Tests (PFTs) — to exclude parenchymal lung disease contributing to hypoxic pulmonary vasoconstriction • Laboratory panel — full blood count, coagulation screen (PT/INR, aPTT), renal and hepatic function, BNP/NT-proBNP, thyroid function, and autoimmune/connective tissue disease panel as indicated • Genetic counselling and testing (BMPR2, ACVRL1, ENG) in familial or early-onset PAH cases • RELATIVE AND ABSOLUTE CONTRAINDICATIONS: • Uncorrected coagulopathy or active anticoagulation with supratherapeutic INR (>2.5) that cannot be safely bridged — relative contraindication; requires individualised haematology input • Active systemic infection or bacteraemia — procedure should be deferred until infection is controlled • Severe contrast allergy without adequate pre-medication protocol — use of carbon dioxide (CO₂) angiography or intracardiac echocardiography as alternatives should be considered • Haemodynamic instability requiring vasopressor support — stabilisation required prior to elective catheterisation • Inability to obtain safe vascular access (e.g., bilateral femoral vein occlusion, superior vena cava syndrome) without alternative access planning (hepatic vein, transhepatic approach)
Treatment Options & Approaches
RIGHT HEART CATHETERISATION APPROACHES AND TECHNIQUES: 1. STANDARD DIAGNOSTIC RIGHT HEART CATHETERISATION (Haemodynamic Profiling): Performed under general anaesthesia (GA) with endotracheal intubation in infants and young children, or conscious sedation with propofol/midazolam/ketamine in cooperative older children. Venous access is established via the right femoral vein using ultrasound-guided Seldinger technique with a 4F–6F introducer sheath appropriate for body weight. A balloon-tipped, flow-directed catheter (paediatric Swan-Ganz or Berman angiographic catheter) is advanced sequentially to measure: right atrial pressure (RAP), right ventricular pressure (RVP — systolic, diastolic, end-diastolic), pulmonary artery pressure (PAP — systolic, diastolic, mean), and pulmonary artery wedge pressure (PAWP) as a surrogate for left atrial pressure. Cardiac output is determined by thermodilution (preferred in patients without significant tricuspid regurgitation or intracardiac shunts) or the direct Fick method (gold standard in shunt quantification, using measured oxygen consumption or assumed Vo₂ by LaFarge equation in children). Oximetry run (oxygen saturation at each chamber level) identifies the anatomical level of any intracardiac shunt and quantifies Qp:Qs. 2. ACUTE VASOREACTIVITY TESTING (AVT): Following baseline haemodynamic acquisition, AVT is performed with inhaled nitric oxide (iNO) at 20 ppm for 10 minutes (preferred agent per ESC/ERS and AHA/ACC guidelines), with repeat haemodynamic measurements. Alternative agents include intravenous adenosine (50–200 mcg/kg/min) and inhaled iloprost (a prostacyclin analogue). Response is graded using the Sitbon criteria. A positive response identifies the subgroup of PAH patients who may benefit from high-dose calcium channel blocker (CCB) therapy (nifedipine, diltiazem, or amlodipine) rather than advanced PAH-targeted agents (endothelin receptor antagonists such as bosentan/macitentan; PDE-5 inhibitors such as sildenafil/tadalafil; prostacyclin analogues such as epoprostenol, treprostinil, or iloprost; or sGC stimulators such as riociguat). 3. COMBINED DIAGNOSTIC AND INTERVENTIONAL CATHETERISATION: In many paediatric cases, diagnostic RHC is combined in a single session with a therapeutic intervention to avoid repeat anaesthesia. Interventions may include: • Transcatheter device closure of secundum ASD (using Amplatzer Septal Occluder, Gore Cardioform, or equivalent) or muscular/perimembranous VSD (Amplatzer Muscular VSD Occluder or ADO II AS device) • Balloon pulmonary valvuloplasty (BPV) for pulmonary valve stenosis, using Tyshak or Z-Med balloon catheters sized to annulus diameter by Noonan criteria • Branch pulmonary artery (PA) balloon angioplasty ± cutting balloon angioplasty for discrete PA stenosis, and high-pressure balloon-expandable stent implantation (Palmaz Genesis, Formula, or Atlas Gold stents) for resistant PA stenosis in patients above minimum weight thresholds • Blade atrial septostomy or radiofrequency-assisted perforation with balloon septostomy for decompression of the left atrium in obstructed TAPVC or as a palliative measure in severe PAH • Pulmonary arteriovenous malformation (PAVM) embolisation using coils or vascular plugs (Amplatzer Vascular Plug II/IV) 4. ADVANCED IMAGING-INTEGRATED CATHETERISATION: • 3D Rotational Angiography (3DRA): Single contrast injection with C-arm rotation generates a 3D reconstructed roadmap of cardiac and vascular anatomy, significantly reducing contrast volume and radiation dose — critical in small children • Intracardiac Echocardiography (ICE): Real-time catheter-based ultrasound imaging eliminates the need for TOE probes in small children, providing intraprocedural anatomical guidance for device closure • Pressure-Wire Fractional Flow Reserve (FFR): Used in complex PA stenosis assessment to determine haemodynamic significance of intermediate stenoses before committing to stent implantation • Hybrid Catheterisation-Operating Room (Hybrid OR / Hybrid Suite): Available at the highest-tier centres, enabling simultaneous surgical access (sternotomy or thoracotomy) with catheterisation capabilities for ultra-complex congenital lesions (e.g., perventricular VSD closure, hybrid stage 1 palliation for hypoplastic left heart syndrome) 5. RADIATION DOSE OPTIMISATION: Leading paediatric catheterisation centres implement ALARA (As Low As Reasonably Achievable) protocols including pulsed fluoroscopy at low frame rates (7.5–15 frames/second), collimation, lead gonadal shielding, and dose-tracking software (e.g., DoseMap, SENTINEL). The CATH-PCI and IMPACT registry benchmarks are used for quality monitoring.
Recovery
PRE-PROCEDURE PHASE (4–6 weeks before travel): • Step 1 — Virtual Consultation with GAF Healthcare: Paediatric cardiologist reviews all existing records, imaging (echo reports, CMR, CTPA), and genetic/laboratory results. A pre-travel case summary is generated and a procedural plan is confirmed. • Step 2 — Pre-Admission Diagnostic Workup (on arrival or within 48–72 hours): Repeat TTE/Doppler by the local team, updated BNP/NT-proBNP, full blood count, coagulation, renal and hepatic panel, and paediatric anaesthesia pre-assessment (airway assessment, weight-based drug planning). Any elective medications affecting coagulation (e.g., aspirin, anticoagulants) are managed per anaesthesia protocol. • Step 3 — Anaesthesia and Cardiology Team Briefing: A joint paediatric cardiac catheterisation conference reviews anatomy, planned haemodynamic targets, and contingency plans for haemodynamic instability or arrhythmia. PROCEDURE DAY: • Step 4 — Fasting and Pre-Medication: Clear fluids until 2 hours pre-procedure (ESAIC guidelines); weight-appropriate anxiolytic pre-medication (oral midazolam 0.3–0.5 mg/kg) administered 30–45 minutes before induction. • Step 5 — Anaesthesia Induction: General anaesthesia with propofol or sevoflurane induction, followed by LMA or endotracheal intubation depending on age and airway assessment. Continuous invasive arterial pressure monitoring (radial artery line) and pulse oximetry are established. • Step 6 — Catheterisation Procedure: Ultrasound-guided femoral venous access, heparin anticoagulation (100 units/kg IV bolus, target ACT 200–250 seconds), sequential catheter advancement, haemodynamic data collection, oximetry run, angiography, and — if indicated — acute vasoreactivity testing and/or therapeutic intervention. Total procedure time: 60–180 minutes depending on complexity. • Step 7 — Closure and Haemostasis: Sheath removal with manual compression (typically 10–15 minutes for 4F–6F sheaths in children); vascular closure devices are used sparingly in paediatric patients given vessel size. Protamine reversal of heparin is administered if early ambulation is required. POST-PROCEDURE RECOVERY — DAY 0 (Procedure Day): • Transfer to Paediatric Cardiac ICU (PCICU) or High Dependency Unit (HDU) for 4–6 hours monitoring: continuous ECG, pulse oximetry, non-invasive BP, and observation for access-site haematoma, arterial spasm, or cardiac arrhythmia. • Restart of oral fluids when fully awake; early mobilisation encouraged in older children. • Discharge from PCICU to ward if observations stable. RECOVERY MILESTONES: • Day 1 (Post-Procedure): Clinical review by paediatric cardiologist; repeat TTE to confirm no new pericardial effusion or procedural complications; access site review. Most diagnostic-only RHC patients are discharged on Day 1. • Day 2–3: Patients who underwent concurrent interventional procedures (device closure, stenting) remain hospitalised for telemetry, antiplatelet therapy initiation (aspirin 3–5 mg/kg/day for ASD/VSD device closure), and post-interventional echocardiography. • Day 5–7: Outpatient review with cardiologist; haemodynamic report and final catheterisation data interpreted in the context of the clinical case; PAH medication titration initiated if applicable. Child may begin light activity. • Day 7–14 (Fit-to-Fly Clearance): Physician issues formal fit-to-fly certificate. Short-haul flights (<4 hours) may be cleared at Day 5–7 for uncomplicated diagnostic cases. Long-haul flights require stability at Day 10–14. Supplemental in-flight oxygen is recommended for children with resting SpO₂ <92% or significant PAH.
Risks to be aware of
Right Heart Catheterisation is widely regarded as a safe procedure in experienced paediatric cardiac centres, with major complication rates below 1–2% at high-volume institutions. However, patients and families must be fully informed of the following procedure-specific risks: Vascular Access Complications: Haematoma, arteriovenous fistula, pseudoaneurysm, or femoral vein thrombosis at the puncture site occur in fewer than 1–2% of cases. Femoral artery spasm (particularly in neonates and infants) is more common and is managed with topical nitroglycerine and, if persistent, intraarterial vasodilators. Vessel injury requiring surgical repair is rare (<0.1%). Cardiac Arrhythmias: Catheter-induced transient arrhythmias — including right bundle branch block (RBBB), supraventricular tachycardia (SVT), or ventricular ectopy — occur during catheter manipulation through the right ventricle and pulmonary outflow tract. Sustained life-threatening arrhythmias requiring cardioversion or defibrillation are rare (<0.5%) and are managed with continuous ECG monitoring and crash cart availability in all catheterisation laboratories. Acute Vasoreactivity Testing (AVT) Risks: Inhaled nitric oxide and intravenous adenosine can precipitate acute haemodynamic deterioration, including severe systemic hypotension and right heart failure, in patients with severely elevated fixed pulmonary vascular resistance. AVT must only be performed in centres with PCICU backup and provision for emergent venoarterial extracorporeal membrane oxygenation (VA-ECMO) rescue. Contrast-Related Risks: Contrast-induced nephropathy is rare in children with normal baseline renal function. Pre-hydration protocols and use of iso-osmolar, non-ionic contrast agents (iodixanol, iohexol) minimise risk. Known contrast allergy requires pre-medication with corticosteroids and antihistamines, or use of CO₂ angiography as an alternative. Radiation Exposure: All paediatric catheterisation carries an inherent radiation risk. Accredited centres adhere to ALARA protocols and dose-benchmarking registries (IMPACT, C3PO). Cumulative radiation dose is documented and communicated to the referring physician for longitudinal tracking. Perforation and Tamponade: Cardiac perforation with pericardial tamponade is a rare but life-threatening complication (incidence <0.1% in diagnostic RHC). It is most frequently associated with concurrent interventional procedures. Emergency pericardiocentesis and surgical backup must be immediately available. Anaesthesia-Related Risks: Paediatric patients — particularly infants and neonates — carry baseline anaesthetic risks including laryngospasm, bronchospasm, and haemodynamic instability during induction, particularly in the setting of elevated PAP and right ventricular dysfunction. Dedicated paediatric cardiac anaesthesiologists with pulmonary hypertension experience substantially mitigate these risks. Procedure-specific mortality in elective diagnostic RHC at high-volume paediatric cardiac centres is exceptionally low (<0.1%). Families are encouraged to discuss the complete risk-benefit profile with the GAF Healthcare-assigned paediatric cardiologist during the pre-travel virtual consultation.
Why GAF Healthcare
GAF Healthcare provides end-to-end, non-medical coordination for international paediatric cardiac patients travelling to India or the UAE, ensuring that families can focus entirely on their child's care and recovery. MEDICAL VISA ASSISTANCE — INDIA: GAF Healthcare prepares and submits the complete Indian e-Medical Visa application on behalf of the patient and up to two accompanying attendants (e-Medical Attendant Visa). Required documents — including the invitation letter from the treating hospital (mandatory for Indian e-Medical Visa), medical records summary, and passport copies — are compiled and submitted through the official Indian Government portal. Processing times are typically 3–5 business days. GAF Healthcare's case coordinators track application status and liaise with the Indian High Commission or Embassy in the patient's home country as needed. The e-Medical Visa is valid for up to 60 days and permits multiple entries. VISA FACILITATION — UAE (DUBAI / ABU DHABI): The UAE offers visa-on-arrival privileges for citizens of over 50 countries, including GCC nationals, EU and UK citizens, and holders of valid US, UK, or Schengen visas. For patients from countries requiring pre-arranged entry visas, GAF Healthcare facilitates a medical treatment entry visa through the treating hospital's international patient services department. Processing takes 3–7 business days. A DHA (Dubai Health Authority) or DOH (Abu Dhabi Department of Health) registered hospital invitation letter is provided by GAF Healthcare to support the visa application. AIRPORT TRANSFERS: Dedicated private vehicle transfers (saloon or multi-purpose vehicle with child car seat provision) are arranged between the international airport and the hospital or accommodation upon arrival and departure. Transfer drivers are briefed on the patient's condition and carry the GAF Healthcare emergency contact card with 24/7 support numbers. DEDICATED PATIENT COORDINATOR AND TRANSLATORS: Each case is assigned a named GAF Healthcare Patient Coordinator who serves as the single point of contact from pre-departure through post-discharge follow-up. The coordinator attends hospital appointments with the family, assists with informed consent documentation review, and ensures communication clarity between the medical team and the family. Professional medical interpreters are available in over 30 languages — including Arabic, Russian, French, Swahili, Bengali, and Tagalog — at no additional cost to the patient. ATTENDANT ACCOMMODATION: GAF Healthcare arranges accommodation for up to two accompanying family members within walking distance or a short transfer from the treating hospital, ranging from budget guesthouses to serviced apartments and Ronald McDonald House-equivalent facilities (where available). Accommodation options are vetted for hygiene, safety, and proximity to paediatric cardiac centres. For extended stays exceeding two weeks, long-term serviced apartment packages with cooking facilities are arranged to reduce food costs and improve family comfort. POST-DISCHARGE FOLLOW-UP: A structured telemedicine follow-up plan is established before departure. The treating cardiologist provides a detailed discharge summary, catheterisation haemodynamic report, procedural images (CD/digital format), and a medication reconciliation letter translated into the patient's home country language. GAF Healthcare coordinates transmission of records to the patient's local cardiologist and schedules a 4–6 week virtual review with the treating team.
Common questions about Right Heart Catheterization
What is the cost of Right Heart Catheterisation in India versus the UAE?
How long does my child need to stay in the country before they are fit to fly home?
What is the success rate of Right Heart Catheterisation in children, and how safe is the procedure?
How GAF Healthcare Assists in Choosing the Best Hospital for Right Heart Catheterization in Mumbai, India
Discover the Top Hospitals for Right Heart Catheterization in Mumbai, India
This page lists 17 accredited paediatric cardiology hospitals in Mumbai, India, so you can compare accreditation, specialties and bed capacity in one place.
Support When You Need It Most
Share your medical reports with us on WhatsApp or email. Our medical team reviews them and comes back with a recommended hospital and treatment plan for your case.
Transparent, All-Inclusive Costs
We provide a single, itemised quote covering hospital charges and stay — no hidden fees, and there's no charge for requesting an estimate. Use our cost calculator alongside this page for a first estimate.
Visa, Travel and Stay Coordination
Once you choose a hospital, we help arrange the medical visa invitation letter, hotel or serviced-apartment booking nearby, airport pickup and transport to your appointments.
Curious what treatment might cost for your case? Use our cost calculator for a personalized estimate.
Frequently asked questions about right heart catheterization in Mumbai, India
How many paediatric cardiology hospitals are listed in Mumbai, India?
How do you choose which hospitals to list?
How much does treatment cost in India?
Are there paediatric cardiology hospitals for this in other India cities?
Next Step
Share your medical reports with us and our team will recommend a hospital and treatment plan for right heart catheterization in Mumbai, India.
Contact us to report an inaccuracy on this page.